{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:59:46Z","timestamp":1779191986643,"version":"3.51.4"},"reference-count":48,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["headachejournal.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Headache"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe the pattern of triptan use by gender in Tuscany, Italy, focusing on special user populations in which evidence on triptan safety is still not conclusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Growing evidence supports the role of gender differences in migraine pathophysiology and treatment. However, gender impact on triptan real\u2010word utilization has been poorly investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective, descriptive, cohort study was performed using the population\u2010based Administrative Healthcare Database of Tuscany region (Italy). Subjects registered in the database on the January 1 of each year between 2008 and 2018 were identified.\n                      <jats:italic>New users<\/jats:italic>\n                      (NU) of triptans (ATC:N02CC*) were patients with one or more triptan dispensation during the year of interest and none in the past. Age, cardiovascular comorbidities representing an absolute or a possible contraindication to triptan utilization, concomitant serotonergic medications, and pattern of triptan use during 1\u2010year follow\u2010up were described by gender.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 86,109 patients who received one or more triptan dispensing were identified. Of 64,672 NU (men\u00a0=\u00a017,039; women\u00a0=\u00a047,633), 10.2% (6823\/64,672) were aged &gt;65\u2009years, who were mostly women (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a04613). Among NU, men and women with absolute cardiovascular contraindications were 4.3% (740\/17,039) and 2.1% (1022\/47,633), respectively, while those concomitantly taking serotonergic medications were 17.2% (267\/1549) and 21.9% (949\/4330), respectively (949\/4330). Regular users (two or more dispensing with \u22653\u2009months between first and last observed dispensing) accounted for 26.4% of women (12,597\/47,633) and 19.11% of men (3250\/17,039); frequent users (\u226515\u2009dosage units\/month during \u22653 consecutive months) were overall 0.1% (94\/64,672) and 62.0% (58\/94) of them concomitantly received serotonergic medications.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Considering gender differences in triptan use highlighted here, large scale observational studies are warranted to better define what populations are safe to use triptans and whether it is appropriate to tighten or relax certain recommendations on triptan use. In the meantime, any suspected adverse drug reaction observed in the special user populations highlighted in this study should be promptly reported.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/head.14463","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T07:39:43Z","timestamp":1674805183000},"page":"222-232","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Utilization patterns, cardiovascular risk, and concomitant serotoninergic medications among triptan users between 2008 and 2018: A gender analysis in one Italian region, Tuscany"],"prefix":"10.1111","volume":"63","author":[{"given":"Giulia","family":"Hyeraci","sequence":"first","affiliation":[{"name":"Agenzia regionale di sanit\u00e0 della Toscana (ARS)  Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Gini","sequence":"additional","affiliation":[{"name":"Agenzia regionale di sanit\u00e0 della Toscana (ARS)  Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Bezin","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Unit Univ. Bordeaux, INSERM, BPH, Team Pharmacoepidemiology, U1219, CHU de Bordeaux  Bordeaux France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi Francesco","family":"Iannone","sequence":"additional","affiliation":[{"name":"Headache Centre, Careggi University Hospital, Department of Health Sciences University of Florence  Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Benemei","sequence":"additional","affiliation":[{"name":"Headache Centre, Careggi University Hospital, Department of Health Sciences University of Florence  Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Lupi","sequence":"additional","affiliation":[{"name":"Area Vasta Centro Ethics Committee Secretariat \u2010 Clinical Trial Unit for Phase 1 Trials Careggi University Hospital  Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"De\u00a0Cesaris","sequence":"additional","affiliation":[{"name":"Headache Centre, Careggi University Hospital, Department of Health Sciences University of Florence  Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierangelo","family":"Geppetti","sequence":"additional","affiliation":[{"name":"Headache Centre, Careggi University Hospital, Department of Health Sciences University of Florence  Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Roberto","sequence":"additional","affiliation":[{"name":"Agenzia regionale di sanit\u00e0 della Toscana (ARS)  Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,1,27]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32154-2"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01208-0"},{"key":"e_1_2_9_4_1","volume-title":"Atlas of Headache Disorders and Resources in the World 2011","author":"WHO","year":"2011"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-1027-7"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)30293-9"},{"key":"e_1_2_9_7_1","unstructured":"FestaD SordiniV VedovatiG.Linee guida per la diagnosi e la terapia delle cefalee primarie:141."},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-012-0437-6"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1076-6"},{"key":"e_1_2_9_10_1","unstructured":"Sumatriptan package leaflet.https:\/\/www.medicines.org.uk\/emc\/files\/pil.1257.pdf"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2004.04078.x"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102413499649"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102414550416"},{"issue":"3","key":"e_1_2_9_14_1","first-page":"48","article-title":"Alert on serotonin syndrome with combined use of SSRIs or SNRIs and triptans: an analysis of the 29 case reports","volume":"9","author":"Evans RW","year":"2007","journal-title":"Medscape Gen Med"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/1178646919873925"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102415570497"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-008-0020-3"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102421991809"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420905307"},{"issue":"15","key":"e_1_2_9_20_1","article-title":"Triptan use and discontinuation in a representative sample of persons with migraine: results from Migraine in America Symptoms and Treatment (MAST) study (P4.10\u2010019)","volume":"92","author":"Alam A","year":"2019","journal-title":"Neurology"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13642"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-001-0070-6"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-020-02867-4"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2476"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-019-0334-y"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/02813430500444916"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2007.01401.x"},{"key":"e_1_2_9_28_1","first-page":"576","volume-title":"Rapporto Nazionale","author":"L'uso dei farmaci in Italia","year":"2019"},{"key":"e_1_2_9_29_1","unstructured":"GALLERY\u00ae\u2010 Compendio Farmaceutico WEB \u2013 \u00a9Farmadati Italia.https:\/\/gallery.farmadati.it\/Home.aspx"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008095"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/2047487315589011"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200326020-00003"},{"key":"e_1_2_9_33_1","first-page":"27","article-title":"Subcutaneous delivery of sumatriptan in the treatment of migraine and primary headache","volume":"6","author":"Moore JC","year":"2012","journal-title":"Patient Prefer Adherence"},{"key":"e_1_2_9_34_1","article-title":"Estimating the risk for serotonin syndrome with triptan and SSRI or SNRI coprescription","author":"Silver J","year":"2018","journal-title":"NEJM J Watch"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2010.01691.x"},{"issue":"15","key":"e_1_2_9_36_1","article-title":"Reality or myth: serotonin syndrome in migraineurs with triptan use (S27.005)","volume":"92","author":"Kerr M","year":"2019","journal-title":"Neurology"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.5144"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2006.00435.x"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2009.02001.x"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2007.00752.x"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0864-0"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0875-x"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01213-3"},{"key":"e_1_2_9_44_1","unstructured":"Popolazione residente al 1\u00b0 gennaio: Toscana.http:\/\/dati.istat.it\/Index.aspx?QueryId=18561#"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-018-0732-5"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-017-0815-1"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1177\/2150132720963680"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2006.00691.x"},{"key":"e_1_2_9_49_1","volume-title":"A Validation Odyssey: from Big Data to Local Intelligence Validity of Case Finding Algorithms and of Measures of Quality of Care for Chronic Diseases in Italian Administrative Databases","author":"Gini R","year":"2016"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.14463","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/head.14463","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.14463","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:22:57Z","timestamp":1762075377000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/head.14463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,27]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1111\/head.14463"],"URL":"https:\/\/doi.org\/10.1111\/head.14463","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,27]]},"assertion":[{"value":"2022-04-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}